×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
LRRK2 Antikörper (C-Term)
LRRK2
Reaktivität: Human, Maus
Wirt: Maus
Monoclonal
133AT1218
unconjugated
Produktdetails anti-LRRK2 Antikörper
(ausblenden)
Target
Alle LRRK2 Antikörper anzeigen
LRRK2
(Leucine-Rich Repeat Kinase 2 (LRRK2))
Bindungsspezifität
Alle Epitope für LRRK2 Antikörper
C-Term
Reaktivität
Human, Maus
Wirt
Alle Wirte für LRRK2 Antikörper
Maus
Klonalität
Alle Klonalitäten für LRRK2 Antikörper
Monoklonal
Konjugat
Alle Konjugate für LRRK2 Antikörper
Dieser LRRK2 Antikörper ist unkonjugiert
Applikation
Bitte anfragen
Aufreinigung
This antibody is purified through a protein G column, followed by dialysis against PBS.
Immunogen
This PARK8 (LRRK2) antibody was raised in mice using purified His-tagged recombinant protein comprised of the C-terminal 261 residues of LRRK2.
Klon
133AT1218
Isotyp
IgG1
Top Product
Discover our top product LRRK2 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
IHC: 1:50
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Haltbarkeit
6 months
Referenzen für anti-LRRK2 Antikörper (ABIN387804)
(ausblenden)
Ortiz-Ortiz, Morán, Ruiz-Mesa, Niso-Santano, Bravo-SanPedro, Gómez-Sánchez, González-Polo, Fuentes : "Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. " in: Neuroscience letters , Vol. 468 , Issue 2 , pp. 120-4 , (2009 ) (PubMed ).
Biskup, Moore, Rea, Lorenz-Deperieux, Coombes, Dawson, Dawson, West : "Dynamic and redundant regulation of LRRK2 and LRRK1 expression. " in: BMC neuroscience , Vol. 8 , pp. 102 , (2008 ) (PubMed ).
Details zu LRRK2
(ausblenden)
Target
LRRK2
(Leucine-Rich Repeat Kinase 2 (LRRK2))
Andere Bezeichnung
PARK8 (LRRK2) (LRRK2 Produkte )
Synonyme
LRRK2 antikoerper, AURA17 antikoerper, DARDARIN antikoerper, PARK8 antikoerper, RIPK7 antikoerper, ROCO2 antikoerper, 4921513O20Rik antikoerper, 9330188B09Rik antikoerper, AW561911 antikoerper, D630001M17Rik antikoerper, Gm927 antikoerper, cI-46 antikoerper, leucine-rich repeat kinase 2 antikoerper, leucine rich repeat kinase 2 antikoerper, lrrk2 antikoerper, LRRK2 antikoerper, Lrrk2 antikoerper
Hintergrund
This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8.
Molekulargewicht
286103
Gen-ID
120892
NCBI Accession
NP_940980
UniProt
Q5S007
Pathways
Regulation of G-Protein Coupled Receptor Protein Signaling , Skeletal Muscle Fiber Development
Zuletzt angesehen
(ausblenden)